Fund Holdings — NEA Management Company, LLC

Total Portfolio Value:
$1.82B
Total Bought:
$7.10M
Total Sold:
$128.45M
Net Transaction:
-$121.35M
Notable People:
Anthony Angelo Florence, Mohamad Hassan Makhzoumi
Securities
▲▼
SharesValue
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Rhythm Pharmaceuticals, Inc.(RYTM)2,909,9562,909,9560$183.88M$293.88M16.13%+$110.00M
Arcellx Inc
COMMON STOCK
3,745,2623,045,262-700,000$246.63M$250.02M13.72%+$3.39M
Verona Pharma PlcADS2,263,1382,252,994-10,144$214.05M$240.42M13.19%+$26.37M
Coursera, Inc.(COUR)12,867,76912,867,7690$112.72M$150.68M8.27%+$37.96M
Trevi Therapeutics, Inc.(TRVI)13,222,22813,222,2280$72.33M$120.98M6.64%+$48.66M
Celcuity Inc.(CELC)2,294,2612,144,261-150,000$30.63M$105.93M5.81%+$75.30M
Savara Inc.(SVRA)24,471,26424,471,2640$55.79M$87.36M4.79%+$31.57M
CRISPR Therapeutics AGNAMEN AKT(CRSP)1,587,8541,058,570-529,284$77.23M$68.61M3.76%-$8.63M
MBX Biosciences, Inc.(MBX)3,614,4863,614,4860$41.24M$63.25M3.47%+$22.01M
Zenas BioPharma, Inc.(ZBIO)2,733,7192,733,7190$26.49M$60.69M3.33%+$34.20M
Monte Rosa Therapeutics, Inc.(GLUE)7,692,2987,692,2980$34.69M$57.00M3.13%+$22.31M
Korro Bio, Inc.(KRRO)1,090,7931,090,7930$13.62M$52.24M2.87%+$38.61M
ORIC Pharmaceuticals, Inc.(ORIC)4,118,6214,118,6210$41.80M$49.42M2.71%+$7.62M
Gossamer Bio, Inc.(GOSS)18,093,03418,093,0340$22.25M$47.58M2.61%+$25.33M
Aurinia Pharmaceuticals Inc.(AUPH)3,969,8343,969,8340$33.62M$43.87M2.41%+$10.24M
Phathom Pharmaceuticals, Inc.(PHAT)1,960,1691,960,1690$18.80M$23.07M1.27%+$4.27M
Neuehealth Inc2,726,9172,726,9170$18.82M$18.19M1.00%-$627.2K
Black Diamond Therapeutics I4,448,7574,448,7570$11.03M$16.86M0.93%+$5.83M
CVRx, Inc.(CVRX)2,026,0832,026,0830$11.91M$16.35M0.90%+$4.44M
Champions Oncology, Inc.(CSBR)1,713,7201,713,7200$12.63M$11.10M0.61%-$1.53M
Inventiva S.A.ADS(IVA)1,462,5861,462,5860$4.67M$8.32M0.46%+$3.66M
Omada Health, Inc.(OMDA)364,115364,1150$6.66M$8.05M0.44%+$1.39M
X4 Pharmaceuticals, Inc.(XFOR)499,5592,233,743+1,734,184$949.2K$7.64M0.42%+$6.69M
Nkarta, Inc.(NKTX)3,568,7813,568,7810$5.92M$7.39M0.41%+$1.46M
Senti Biosciences Inc
COM NEW
3,775,6153,775,6150$7.97M$5.32M0.29%-$2.64M
Synlogic, Inc.(SYBX)2,922,7722,922,7720$3.71M$4.88M0.27%+$1.16M
Marker Therapeutics, Inc.(MRKR)1,625,6781,625,6780$2.49M$1.45M0.08%-$1.04M
OnKure Therapeutics, Inc.CL A(OKUR)478,548478,5480$1.14M$1.32M0.07%+$172.3K
ImageneBio, Inc.(IMA)050,005+50,005$0$407.5K0.02%+$407.5K
Adaptimmune Therapeutics plcADR(ADAPY)17,079,7780-17,079,778$4.09M$0—-$4.09M
Ikena Oncology Inc600,0630-600,063$804.1K$0—-$804.1K
Inozyme Pharma Inc2,437,6890-2,437,689$9.75M$0—-$9.75M
Wheels Up Experience Inc.CL A(UP)106,1250-106,125$113.6K$0—-$113.6K
Page 1 of 1
NEA Management Company, LLC — 13F Holdings — Q3 2025 | TickerTrail